Papers

Peer-reviewed literature with structured metadata.

Trials

Interventional and observational studies by status and phase.

Topics

Key themes across evidence, policy, and outcomes.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across policy and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

News

Announcements, funding, and regulatory movement.

Research recaps

Weekly evidence summaries with key takeaways.

Map of research

Landscape views of compounds, trials, and outcomes.

Clinical research

Clinical pipeline tracking by indication and sponsor.

Podcast

Conversations with investigators and policy leaders.

Newsletter

Updates on trials, funding, policy, and new papers.

Guides

Practical explainers on methodology and safety.

Pricing
Back to Research Groups
Health EconomistsRetreats

MAPS

2 Papers

The description of the stakeholder

Research Papers

2
Open Accessindividual

Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Six Phase 2 Trials

This long-term follow-up study (n=107) examines the effects of MDMA-assisted psychotherapy on PTSD symptoms. It finds a significant reduction in PTSD symptoms both at treatment exit and at least 12 months post-treatment, with 67% of participants no longer meeting PTSD criteria at long-term follow-up.

Published
June 4, 2020
Journal
Journal of Psychopharmacology
Authors
Doblin, R., Emerson, A., Feduccia, A. A., Hamilton, S., Jerome, L., Mithoefer, M. C., Wang, J. B., Yazar-Klosinski, B.
Open Accessmeta

Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline

This review (2019) details the potential superiority of MDMA-assisted psychotherapy as a treatment for PTSD compared to the conventional treatment options paroxetine and sertraline.

Published
September 12, 2019
Journal
Frontiers in Psychiatry
Authors
Doblin, R., Emerson, A., Feduccia, A. A., Jerome, L., Mithoefer, M. C., Yazar-Klosinski, B.

Research you can trust, with privacy and clarity built in.

Company

  • About
  • Contact
  • Newsletter
  • Access Program

Product

  • Feedback
  • Roadmap
  • Changelog

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.